A 42-year-woman with a history of juvenile-onset diabetes mellitus was referred to University Hospitals of Cleveland for pancreas transplantation. Diabetes was first diagnosed at age 15, and insulin therapy was begun at that time. At the time of her referral, her serum creatinine concentration was 1.4 mg/dl and the creatinine clearance 80 ml/min. Protein excretion was 1.2 g/24 hrs. Diabetic retinopathy, discovered four years earlier, had been treated with laser surgery. A cadaveric pancreatic transplant was performed using pancreaticoduodenocystotomy. The patient’s postoperative course was complicated by a peripancreatic abscess that required surgical drainage on two occasions. The patient was euglycemic and insulin-independent until one month following surgery, when overt hyperglycemia and a relative decrease in urinary amylase excretion prompted a 10-day course of treatment with OKT3 for presumed acute allograft rejection. Her blood sugar level returned to the normal range; five months later, however, a second rejection episode did not respond to treatment with OKT3. The patient’s pancreatic allograft was surgically removed and insulin therapy was renewed. During the subsequent 18 months, the patient developed peripheral vascular disease requiring a right transmetatarsal amputation; this was followed by a right, below-the-knee amputation. During this interval, the patient’s renal function gradually deteriorated, in part because of two episodes of contrast-medium-induced nephropathy following aortography. She developed end-stage renal disease requiring initiation of maintenance hemodialysis. Two years following the initial pancreatic transplant, the patient received simultaneous kidney and pancreas transplants from one cadaveric donor. Maintenance immunosuppression consisted of cyclosporine, prednisone, and azathioprine. One month following transplantation, the patient was treated with OKT3 for acute renal allograft rejection. Thereafter, she maintained excellent renal allograft function. Glycohemoglobin levels, which had ranged between 8.5% and 9.3% during the six months prior to transplantation, decreased to 4.3% within two months of transplantation. Visual acuity measured within two months after the transplant procedure was 20/300 OD and 20/200 OS. In the seven years following combined kidney-pancreas transplantation, the patient was readmitted to the hospital on 12 occasions. Three separate hospital admissions were prompted by gross hematuria. Cystoscopic evaluation revealed only acute and chronic inflammation of the bladder mucosa and duodenal cuff. Recurrent hematuria prompted enteric conversion of the pancreatic allograft via a pancreaticojejunostomy approximately six years following transplanation. Two years later, the patient developed gangrene of the left foot, which required a left Syme’s amputation. Five years following kidney-pancreas transplantation, the patient published an autobiography detailing how the transplant had improved her quality of life. At last followup, her serum creatinine concentration was 1.1 mg/dl; glycohemoglobin was 3.8%. Visual acuity was 20/30 OD and 20/25 OS.
Read full abstract